Effector CD8 T cells possess suppressor function after 4-1BB and Toll-like receptor triggering.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 12695569.
- Also identified by PMC identifier 154348.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To better understand how innate and adaptive immune responses interact with each other, we combined 4-1BB T cell costimulation with specific adjuvants to determine whether these treatments would influence specific T cell expansion and function in vivo. In the presence of 4-1BB ligation and Toll-like receptor 3 (TLR)3 and/or TLR4 triggering, CD8 T cell clonal expansion and survival was augmented profoundly. Specific T cells primed in vivo with TLR ligands responded normally to in vitro recall stimulus, but, surprisingly, copriming with 4-1BB costimulation significantly impaired the recall response even though many more specific effector T cells were rescued in vivo. Here, we demonstrate that the rescued CD8 T cells suppressed CD4 T cell proliferation via a type beta transforming growth factor-dependent mechanism. Thus, 4-1BB and TLR ligands induce survival of specific effector CD8 T cells with suppressive recall potential, which may explain the dual role that 4-1BB activation plays in mediating tumor clearance and prevention of autoimmune disease.
Medical subject headings
- CD8-Positive T-Lymphocytes
- Drosophila Proteins
- Membrane Glycoproteins
- Receptors, Cell Surface
- Receptors, Nerve Growth Factor
- Receptors, Tumor Necrosis Factor